On July 1, 2015, the first Lipitor diabetes lawsuit trial is set to begin under guidelines of a multidistrict litigation. Lipitor is classified as a statin, a drug prescribed to reduce high cholesterol levels. More than 20 million people in the United States take statins to control their cholesterol.
In July 2013, an initial request to centralize various Lipitor lawsuits related to diabetes in women into a multidistrict litigation (MDL) was rejected because of the small number of filed cases; there were only 24 at the time. More recently, with approximately 500 Lipitor lawsuits filed, a request for consolidation into an MDL was granted. Plaintiffs in this litigation are women who allege that Lipitor use caused them to develop diabetes. Plaintiffs allege they were not warned of this risk by Pfizer, the manufacturer of Lipitor.
Since 2010, studies have shown links between Lipitor and increased blood sugar in women. The Federal Food and Drug Administration (FDA) announced new warnings for Lipitor and other statins but Plaintiffs allege that the warnings are still insufficient to warn doctors and patients of the risk of diabetes in women.
Many Lipitor lawsuits have already been filed, but some project hundreds or even thousands more Lipitor lawsuits will be filed for women in the coming months.
You should always consult a doctor before changing your medication. If you believe that you may have a Lipitor diabetes lawsuit, the experienced attorneys at Lopez McHugh LLP may be able to help.